Financial statements Biostel
Balance sheet data of BIOSTEL
Year
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 495 974,51 | 482 286,16 | 408 948,56 | 284 806,61 |
A. Fixed assets | 122 225,40 | 122 225,40 | 122 225,40 | 122 225,40 |
B. Current assets | 373 749,11 | 360 060,76 | 246 723,16 | 122 581,21 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 40 000,00 | 40 000,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - |
Total liabilities | 495 974,51 | 482 286,16 | 408 948,56 | 284 806,61 |
A. Equity | 495 624,49 | 482 086,16 | 162 248,56 | 155 106,61 |
B. Liabilities and provisions for liabilities | 350,02 | 200,00 | 246 700,00 | 129 700,00 |
I. Long-term liabilities | - | - | - | - |
II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.